A new drug intended to make it easier to clear mucus from the lungs of people with cystic fibrosis showed promising results in a Phase 2 clinical trial. The drug, called SPX-101, blocks the overactive sodium channels that line CF lung cells.
Site Search
Showing 21 - 30 of 134 results
News
|
June 7, 2018
|
2 min read
Today Vertex Pharmaceuticals Inc. announced the two next-generation CFTR modulator candidates that will progress into Phase 3 clinical trials.
News
|
Jan. 31, 2018
|
4 min read
Cystic Fibrosis Foundation Drug Development Model Spawns More Than 30 Promising Therapies
Press Release
|
May 19, 2010
|
3 min read
Press Release
|
Feb. 4, 2008
|
6 min read
Press Release
|
June 9, 2008
|
3 min read
Press Release
|
Oct. 3, 2005
|
5 min read
The Cystic Fibrosis Foundation's Greater New York Chapter recently recognized leading journalist Scott Pelley at the 14th annual Breath of Life Gala for his unwavering dedication to those living with CF.
News
|
Dec. 19, 2017
|
2 min read
Press Release
|
Jan. 18, 2006
|
3 min read
News
|
May 17, 2010
|
3 min read
Press Release
|
July 16, 2008
|
5 min read